ConductScience.org, home

Paper42903495PubMed

Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study.

Hastings WJ and 4 others. Plast Reconstr Surg Glob Open, 2026.

Cite this record

ConductScience Library. Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study. Papers, record 42903495. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42903495

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rapid Wound Healing Observed Following Oral LathMized NAD+ Supplementation: A Case Study.
Journal
Plast Reconstr Surg Glob Open
Year
2026
Publication types
Case Reports, Journal Article
Revised in PubMed
2026-10-23

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hastings WJWaylon J
2Kornilov SASergey A
3Fahey McGrath LLynne
4Komac WWendy
5Ortiz-Pomales YTYan T

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119903300Human skin wounds: a major and snowballing threat to public health and the economy.Wound Repair Regen2009https://conductscience.org/library/papers/19903300PubMed
237424179NAD metabolism: Role in senescence regulation and aging.Aging Cell2024https://conductscience.org/library/papers/37424179PubMed
334936607Complications in Brachioplasty: A Systematic Review and Meta-Analysis.Plast Reconstr Surg2022https://conductscience.org/library/papers/34936607PubMed
442530810Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial.Geroscience2026https://conductscience.org/library/papers/42530810PubMed
518387479Scar treatments: preclinical and clinical studies.J Am Coll Surg2008https://conductscience.org/library/papers/18387479PubMed
636716673SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc.Redox Biol2023https://conductscience.org/library/papers/36716673PubMed
738057866Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis.J Transl Med2023https://conductscience.org/library/papers/38057866PubMed
829074993Epidermal SIRT1 regulates inflammation, cell migration, and wound healing.Sci Rep2017https://conductscience.org/library/papers/29074993PubMed
920566667The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing.Diabetes2010https://conductscience.org/library/papers/20566667PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42903495

GET https://conductscience.org/api/papers/v1/42903495/authors